Pharmafile Logo
Pharmafocus logo
Advanced Search

Onyx

Showing 15 posts of 16 posts found.

dean_forbes

Onyx Health appoints account manager

February 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Onyx, dean forbes

UK healthcare marketing communications firm experts Onyx Health have hired Dean Forbes to develop their marketing, PR and branding services.  …

Appointment

Onyx Health launches women’s health blog

June 26, 2014
Medical Communications A Snapshot of Women’s Health, Onyx, onyx health, women's blog

Healthcare agency Onyx Health has launched its own blog site and online community dedicated to women’s health. In what the …

News
nexavar image

US regulator shows Nexavar green light

November 25, 2013
Sales and Marketing Bayer, Cancer, FDA, Nexavar, Onyx, thyroid

The FDA has extended the indication of liver and kidney cancer pill Nexavar to treat late-stage differentiated thyroid cancer. It …

News
Amgen image

Amgen commits $2.5 million to biotech educational grants

November 12, 2013
Research and Development, Sales and Marketing Amgen, EDC, Onyx, biotech, stem

The Amgen Foundation has announced $2.5 million in new grants for its science programme to aid schools in the US …

News

Columbia Labs buys into pharma outsourcing market

September 16, 2013
Manufacturing and Production Actavis, Columbia Labs, Onyx

News
Otsuka image

Otsuka buys Astex for $866 million

September 6, 2013
Sales and Marketing Astex, Lundbeck, Onyx, Otsuka

Otsuka Pharmaceutical is to buy UK-based Astex Pharmaceuticals in a deal that will see the Tokyo-based firm shelling out $866 …

News
bayer_cross_2

Nexavar gains FDA ‘speed lane’ status for thyroid cancer

August 28, 2013
Research and Development, Sales and Marketing Amgen, Nexavar, Onyx

News
amgen

Amgen buys Onyx for $10.4 billion

August 27, 2013
Research and Development, Sales and Marketing Amgen, Kyprolis, Onyx

News
Amgen image

Onyx rejects Amgen – seeks new suitors

July 2, 2013
Sales and Marketing Amgen, Onyx

Amgen’s advances for Onyx have been knocked back as the biotech firm says it is now seeking new suitors. Onyx …

News
Digital marketing image

Survey: ‘Consultants prefer mailshots’

June 28, 2013
Medical Communications, Sales and Marketing Onyx, digital, mailshots

Pharma should use standard marketing activities such as mailshots if they want to promote their products effectively in UK secondary …

News
Velcade image

Speedy approval for Onyx’ multiple myeloma drug

July 24, 2012
Research and Development, Sales and Marketing FDA, Janssen, Kyprolis, Onyx, Takeda, Velcade

Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma.  Kyprolis (carfilzomib), a …

News
johnosborn

Onyx appoints John Osborn as senior VP

July 20, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing John Osborn, Onyx

Onyx Pharmaceuticals has announced the appointment of John Osborn as senior vice president, Global Corporate Affairs. In his role, Osborn …

Appointment
brian_jolly_at_onyx_scientific_

Onyx appoints Brian Jolly to commercial team

May 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing

Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …

Appointment

Onyx appoints Luigi Costa as its new vice president of Europe

March 7, 2012
Sales and Marketing Luigi Costa, Onyx

Onyx Pharmaceuticals International has appointed Luigi Costa as vice president and head of its European division.  Costa will report to …

Appointment

Onyx Scientific bought by India’s Ipca Labs

August 16, 2011
Manufacturing and Production, Research and Development Ipca, Onyx, contract research news, pharma manufacturing news, research and development news

India’s Ipca Laboratories has bought UK chemistry services firm Onyx Scientific for around £4.6 million ($7.5m). The Mumbai-based company, a …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026